Clinical Trials Browser

Carcinoma × futuximab × Clear all

NCT03549338 2020-09-28

Sym004 Versus Futuximab or Modotuximab in Patients With mCRC

Phase 2 Terminated

2 enrolled 9 charts

Gastrointestinal

Carcinoma, Colorectal Neoplasms

NCT03717038 2019-02-04

Sym004 Versus TAS-102 in Patients With mCRC

Phase 3 Withdrawn

Gastrointestinal

Carcinoma, Colorectal Neoplasms